Nano X Imaging Ltd Asset Resilience Ratio
Nano X Imaging Ltd asset resilience ratio. Nano X Imaging Ltd (NNOX) has an Asset Resilience Ratio of 7.17% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Nano X Imaging Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Nano X Imaging Ltd (2020–2025)
Asset resilience ratio of Nano X Imaging Ltd from 2020 to 2025. This chart shows how Nano X Imaging Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Nano X Imaging Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Nano X Imaging Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Nano X Imaging Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $10.46 Million | 7.17% |
| Total Liquid Assets | $10.46 Million | 7.17% |
Asset Resilience Insights
- Limited Liquidity: Nano X Imaging Ltd maintains only 7.17% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Nano X Imaging Ltd Industry Peers by Asset Resilience Ratio
Compare Nano X Imaging Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Nano X Imaging Ltd Asset Resilience Ratio by Year (2020–2025)
Nano X Imaging Ltd asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for Nano X Imaging Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.45% | $10.46 Million | $162.16 Million | -9.69pp |
| 2024-12-31 | 16.14% | $33.90 Million | $210.00 Million | +4.25pp |
| 2023-12-31 | 11.89% | $26.01 Million | $218.65 Million | -3.53pp |
| 2022-12-31 | 15.42% | $39.16 Million | $253.93 Million | +9.35pp |
| 2021-12-31 | 6.08% | $22.07 Million | $363.17 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $236.15 Million | -- |
About Nano X Imaging Ltd
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source… Read more